{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:08:24Z","timestamp":1776258504193,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/04194-0"],"award-info":[{"award-number":["2015\/04194-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["431465\/2016\u20109"],"award-info":[{"award-number":["431465\/2016\u20109"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Glioblastoma (GB) cells have the ability to migrate and infiltrate the normal parenchyma, leading to the formation of recurrent tumors often adjacent to the surgical extraction site. We recently showed that\n                      <jats:italic>Phoneutria nigriventer<\/jats:italic>\n                      spider venom (PnV) has anticancer effects mainly on the migration of human GB cell lines (NG97 and U-251). The present work aimed to investigate the effects of isolated components from the venom on migration, invasiveness, morphology and adhesion of GB cells, also evaluating RhoA-ROCK signaling and Na\n                      <jats:sup>+<\/jats:sup>\n                      \/K\n                      <jats:sup>+<\/jats:sup>\n                      -ATPase \u03b22 (AMOG) involvement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human (NG97) GB cells were treated with twelve subfractions (SFs\u2014obtained by HPLC from PnV). Migration and invasion were evaluated by scratch wound healing and transwell assays, respectively. Cell morphology and actin cytoskeleton were shown by GFAP and phalloidin labeling. The assay with fibronectin coated well plate was made to evaluate cell adhesion. Western blotting demonstrated ROCK and AMOG levels and a ROCK inhibitor was used to verify the involvement of this pathway. Values were analyzed by the GraphPad Prism software package and the level of significance was determinate using one-way analysis of variance (ANOVA) followed by Dunnett\u2019s multiple comparisons test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two (SF1 and SF11) of twelve SFs, decreased migration and invasion compared to untreated control cells. Both SFs also altered actin cytoskeleton, changed cell morphology and reduced adhesion. SF1 and SF11 increased ROCK expression and the inhibition of this protein abolished the effects of both subfractions on migration, morphology and adhesion (but not on invasion). SF11 also increased Na\n                      <jats:sup>+<\/jats:sup>\n                      \/K\n                      <jats:sup>+<\/jats:sup>\n                      -ATPase \u03b22.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>All components of the venom were evaluated and two SFs were able to impair human glioblastoma cells. The RhoA effector, ROCK, was shown to be involved in the mechanisms of both PnV components. It is possible that AMOG mediates the effect of SF11 on the invasion. Further investigations to isolate and biochemically characterize the molecules are underway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12935-020-01643-8","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T19:26:13Z","timestamp":1608146773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+\/K+-ATPase \u03b22: potential molecular entities to treat invasive brain cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Nat\u00e1lia","family":"Barreto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Pires","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Cezar Pinheiro","family":"de Mato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomaz A. A.","family":"da Rocha\u2010e\u2010Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Sutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Luiz","family":"Vitorino-Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Verinaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-497X","authenticated-orcid":false,"given":"Catarina","family":"Rap\u00f4so","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"issue":"4","key":"1643_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11912-017-0586-5","volume":"19","author":"AC Tan","year":"2017","unstructured":"Tan AC, Heimberger AB, Khasraw M. Immune checkpoint inhibitors in gliomas. Curr Oncol Rep. 2017;19(4):23.","journal-title":"Curr Oncol Rep."},{"issue":"7","key":"1643_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","volume":"14","author":"G Reifenberger","year":"2017","unstructured":"Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M. Advances in the molecular genetics of gliomas-implications for classification and therapy. Nat Rev Clin Oncol. 2017;14(7):434\u201352. https:\/\/doi.org\/10.1038\/nrclinonc.2016.204.","journal-title":"Nat Rev Clin Oncol."},{"issue":"October","key":"1643_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jns.2017.10.025","volume":"383","author":"F Mao","year":"2017","unstructured":"Mao F, Wang B, Xiao Q, Cheng F, Lei T, Guo D. LRIG proteins in glioma: functional roles, molecular mechanisms, and potential clinical implications. J Neurol Sci. 2017;383(October):56\u201360. https:\/\/doi.org\/10.1016\/j.jns.2017.10.025.","journal-title":"J Neurol Sci."},{"issue":"21","key":"1643_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","volume":"35","author":"BM Alexander","year":"2017","unstructured":"Alexander BM, Cloughesy TF. Adult glioblastoma. J Clin Oncol. 2017;35(21):2402\u20139.","journal-title":"J Clin Oncol"},{"issue":"SEP","key":"1643_CR5","first-page":"1","volume":"9","author":"E Alphand\u00e9ry","year":"2018","unstructured":"Alphand\u00e9ry E. Glioblastoma treatments: an account of recent industrial developments. Front Pharmacol. 2018;9(SEP):1\u201331.","journal-title":"Front Pharmacol."},{"issue":"5","key":"1643_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5114\/wo.2014.40559","volume":"18","author":"K Urbanska","year":"2014","unstructured":"Urbanska K, Sokolowska J, Szmidt M, Sysa P. Glioblastoma multiforme\u2014an overview. Wspolczesna Onkol. 2014;18(5):307\u201312.","journal-title":"Wspolczesna Onkol"},{"issue":"3","key":"1643_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","volume":"3","author":"SY Lee","year":"2016","unstructured":"Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 2016;3(3):198\u2013210. https:\/\/doi.org\/10.1016\/j.gendis.2016.04.007.","journal-title":"Genes Dis."},{"issue":"12","key":"1643_CR8","doi-asserted-by":"crossref","first-page":"e1426","DOI":"10.1634\/theoncologist.2017-0603","volume":"24","author":"Y Wang","year":"2019","unstructured":"Wang Y, Pandey M, Ballo MT. Integration of tumor-treating fields into the multidisciplinary management of patients with solid malignancies. Oncologist. 2019;24(12):e1426.","journal-title":"Oncologist"},{"issue":"5","key":"1643_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2017.10.002","volume":"21","author":"W Zhou","year":"2018","unstructured":"Zhou W, Chen C, Shi Y, Wu Q, Gimple RC, Fang X, et al. Targeting glioma stem cell-derived pericytes disrupts the blood-tumor barrier and improves chemotherapeutic efficacy. Cell Stem Cell. 2018;21(5):591\u2013603.","journal-title":"Cell Stem Cell"},{"key":"1643_CR10","doi-asserted-by":"publisher","first-page":"CNS37","DOI":"10.2217\/cns-2019-0003","volume":"8","author":"S Asif","year":"2019","unstructured":"Asif S, Fatima R, Krc R, Bennett J, Raza S. Comparative proteogenomic characterization of glioblastoma. CNS Oncol. 2019;8:CNS37.","journal-title":"CNS Oncol."},{"issue":"2","key":"1643_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.drudis.2015.01.009","volume":"21","author":"E Patridge","year":"2016","unstructured":"Patridge E, Gareiss P, Kinch MS, Hoyer D. An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today. 2016;21(2):204\u20137. https:\/\/doi.org\/10.1016\/j.drudis.2015.01.009.","journal-title":"Drug Discov Today."},{"issue":"1","key":"1643_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4331\/wjbc.v8.i1.4","volume":"8","author":"YN Utkin","year":"2017","unstructured":"Utkin YN. Modern trends in animal venom research - omics and nanomaterials. World J Biol Chem. 2017;8(1):4.","journal-title":"World J Biol Chem"},{"issue":"2","key":"1643_CR13","first-page":"233","volume":"3","author":"C Rap\u00f4so","year":"2017","unstructured":"Rap\u00f4so C. Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives. J Clin Transl Res. 2017;3(2):233\u201349.","journal-title":"J Clin Transl Res"},{"issue":"1","key":"1643_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brainres.2007.02.086","volume":"1149","author":"C Rap\u00f4so","year":"2007","unstructured":"Rap\u00f4so C, Zago GM, da Silva GH, da Cruz-H\u00f6fling MA. Acute blood-brain barrier permeabilization in rats after systemic Phoneutria nigriventer venom. Brain Res. 2007;1149(1):18\u201329.","journal-title":"Brain Res"},{"issue":"9","key":"1643_CR15","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s11064-012-0817-y","volume":"37","author":"C Rap\u00f4so","year":"2012","unstructured":"Rap\u00f4so C, Odorissi PAM, Oliveira ALR, Aoyama H, Ferreira CV, Verinaud L, et al. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem Res. 2012;37(9):1967\u201381.","journal-title":"Neurochem Res"},{"issue":"9","key":"1643_CR16","doi-asserted-by":"publisher","first-page":"e107292","DOI":"10.1371\/journal.pone.0107292","volume":"9","author":"C Rap\u00f4so","year":"2014","unstructured":"Rap\u00f4so C, Miranda Odorissi PA, Savioli SF, Chitarra R, Hell R, Simoes GF, et al. Triggering of protection mechanism against Phoneutria nigriventer spider venom in the brain. PLoS ONE. 2014;9(9):e107292.","journal-title":"PLoS ONE."},{"key":"1643_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuint.2016.04.005","volume":"96","author":"C Rap\u00f4so","year":"2016","unstructured":"Rap\u00f4so C, Bj\u00f6rklund U, Kalapothakis E, Biber B, Da Alice Cruz-H\u00f6fling M, Hansson E. Neuropharmacological effects of Phoneutria nigriventer venom on astrocytes. Neurochem Int. 2016;96:13\u201323. https:\/\/doi.org\/10.1016\/j.neuint.2016.04.005.","journal-title":"Neurochem Int."},{"issue":"2","key":"1643_CR18","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jcp.26935","volume":"234","author":"N dos Barreto Santos","year":"2019","unstructured":"dos Barreto Santos N, Bonfanti AP, da Rocha-e-Silva TAA, da Silva PI, da Cruz-H\u00f6fling MA, Verinaud L, et al. Venom of the Phoneutria nigriventer spider alters the cell cycle, viability, and migration of cancer cells. J Cell Physiol. 2019;234(2):1398\u2013415.","journal-title":"J Cell Physiol."},{"issue":"4","key":"1643_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1023\/A:1012662423863","volume":"21","author":"MC Grippo","year":"2001","unstructured":"Grippo MC, Penteado PF, Carelli EF, Cruz-H\u00f6fling MA, Verinaud L. Establishment and partial characterization of a continuous human malignant glioma cell line: NG97. Cell Mol Neurobiol. 2001;21(4):421\u20138.","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"1643_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10571-005-4959-1","volume":"25","author":"AA Schenka","year":"2005","unstructured":"Schenka AA, Machado CML, Grippo MC, Queiroz LS, Schenka NGM, Chagas CA, et al. Immunophenotypic and ultrastructural validation of a new human glioblastoma cell line. Cell Mol Neurobiol. 2005;25(5):929\u201341.","journal-title":"Cell Mol Neurobiol"},{"key":"1643_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-5-13","volume":"5","author":"CML Machado","year":"2005","unstructured":"Machado CML, Schenka A, Vassallo J, Tamashiro WMSC, Gon\u00e7alves EM, Genari SC, et al. Morphological characterization of a human glioma cell line. Cancer Cell Int. 2005;5:1\u20137.","journal-title":"Cancer Cell Int"},{"key":"1643_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-8-291","volume":"8","author":"CML Machado","year":"2008","unstructured":"Machado CML, Ikemori RY, Zorzeto TQ, Nogueira ACMA, Barbosa SDS, Savino W, et al. Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro. BMC Cancer. 2008;8:1\u201313.","journal-title":"BMC Cancer"},{"issue":"4","key":"1643_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/jemt.20653","volume":"72","author":"CML Machado","year":"2009","unstructured":"Machado CML, Zorzeto TQ, Bianco JER, Rosa RG, Genari SC, Joazeiro PP, et al. Ultrastructural characterization of the new NG97ht human-derived glioma cell line using two different electron microscopy technical procedures. Microsc Res Tech. 2009;72(4):310\u20136.","journal-title":"Microsc Res Tech"},{"issue":"373","key":"1643_CR24","doi-asserted-by":"publisher","first-page":"eaag2196","DOI":"10.1126\/scitranslmed.aag2196","volume":"9","author":"KV Keu","year":"2017","unstructured":"Keu KV, Witney TH, Yaghoubi S, Rosenberg J, Kurien A, Magnusson R, et al. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci Transl Med. 2017;9(373):eaag2196.","journal-title":"Sci Transl Med."},{"issue":"4","key":"1643_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s004320000188","volume":"127","author":"A Giese","year":"2001","unstructured":"Giese A, Westphal M. Treatment of malignant glioma: A problem beyond the margins of resection. J Cancer Res Clin Oncol Suppl. 2001;127(4):217\u201325.","journal-title":"J Cancer Res Clin Oncol Suppl"},{"issue":"6","key":"1643_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.leukres.2006.06.004","volume":"31","author":"S Das Gupta","year":"2007","unstructured":"Das Gupta S, Debnath A, Saha A, Giri B, Tripathi G, Vedasiromoni JR, et al. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leuk Res. 2007;31(6):817\u201325.","journal-title":"Leuk Res"},{"issue":"3","key":"1643_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1745-7254.2005.00052.x","volume":"26","author":"L Gao","year":"2005","unstructured":"Gao L, Shan BE, Chen J, Liu JH, Song DX, Zhu BC. Effects of spider Macrothele raven venom on cell proliferation and cytotoxicity in HeLa cells. Acta Pharmacol Sin. 2005;26(3):369\u201376.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1643_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41598-020-62620-9","volume":"10","author":"AP Bonfanti","year":"2020","unstructured":"Bonfanti AP, Barreto N, Munhoz J, et al. Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model. Sci Rep. 2020;10(1):16.","journal-title":"Sci Rep."},{"issue":"6","key":"1643_CR29","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s11064-017-2272-2","volume":"42","author":"XT Qi","year":"2017","unstructured":"Qi XT, Zhan JS, Xiao LM, Li L, Xu HX, Fu ZB, et al. The unwanted cell migration in the brain: glioma metastasis. Neurochem Res. 2017;42(6):1847\u201363.","journal-title":"Neurochem Res"},{"key":"1643_CR30","doi-asserted-by":"crossref","unstructured":"Cruz-Hofling MA, Tavares JC, Rap\u00f4so C. Phoneutria nigriventer Venom: Action in the Central Nervous System. Spider Venoms. 2016.","DOI":"10.1007\/978-94-007-6389-0_1"},{"issue":"6","key":"1643_CR31","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1074\/jbc.M111.311688","volume":"287","author":"AK Rooj","year":"2012","unstructured":"Rooj AK, McNicholas CM, Bartoszewski R, Bebok Z, Benos DJ, Fuller CM. Glioma-specific cation conductance regulates migration and cell cycle progression. J Biol Chem. 2012;287(6):4053\u201365.","journal-title":"J Biol Chem"},{"issue":"12","key":"1643_CR32","doi-asserted-by":"publisher","first-page":"14259","DOI":"10.18632\/oncotarget.7423","volume":"7","author":"L Edalat","year":"2016","unstructured":"Edalat L, Stegen B, Klumpp L, Haehl E, Schilbach K, Lukowski R, et al. BK K+ channel blockade inhibits radiation-induced migration\/brain infiltration of glioblastoma cells. Oncotarget. 2016;7(12):14259\u201378.","journal-title":"Oncotarget"},{"issue":"5\u20136","key":"1643_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1023\/A:1021836403433","volume":"22","author":"MV Gomez","year":"2002","unstructured":"Gomez MV, Kalapothakis E, Guatimosim C, Prado MAM. Phoneutria nigriventer venom: a cocktail of toxins that affect ion channels. Cell Mol Neurobiol. 2002;22(5\u20136):579\u201388.","journal-title":"Cell Mol Neurobiol"},{"key":"1643_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-6389-0_6","author":"ME De Lima","year":"2015","unstructured":"De Lima ME, Figueiredo SG, Matavel A, Pedrosa K, Nuens C. Phoneutria nigriventer venom and toxins a review. Spider Venoms. 2015. https:\/\/doi.org\/10.1007\/978-94-007-6389-0_6.","journal-title":"Spider Venoms"},{"key":"1643_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.toxicon.2017.02.001","volume":"129","author":"NF Nicoletti","year":"2017","unstructured":"Nicoletti NF, Erig TC, Zanin RF, Roxo MR, Ferreira NP, Gomez MV, et al. Pre-clinical evaluation of voltage-gated calcium channel blockers derived from the spider P. nigriventer in glioma progression. Toxicon. 2017;129:58\u201367. https:\/\/doi.org\/10.1016\/j.toxicon.2017.02.001.","journal-title":"Toxicon."},{"issue":"1","key":"1643_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev.cellbio.011209.122036","volume":"26","author":"ML Gardel","year":"2010","unstructured":"Gardel ML, Schneider IC, Aratyn-Schaus Y, Waterman CM. Mechanical integration of actin and adhesion dynamics in cell migration. Annu Rev Cell Dev Biol. 2010;26(1):315\u201333.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"1643_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","volume":"100","author":"L Lamalice","year":"2007","unstructured":"Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res. 2007;100(6):782\u201394.","journal-title":"Circ Res"},{"issue":"5651","key":"1643_CR38","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1092053","volume":"302","author":"AJ Ridley","year":"2003","unstructured":"Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: integrating signals from front to back. Science (80- ). 2003;302(5651):1704\u20139.","journal-title":"Science (80- )."},{"issue":"8","key":"1643_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrc3105","volume":"11","author":"N Prevarskaya","year":"2011","unstructured":"Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer. 2011;11(8):609\u201318. https:\/\/doi.org\/10.1038\/nrc3105.","journal-title":"Nat Rev Cancer."},{"issue":"2","key":"1643_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ncb2906","volume":"16","author":"FC Tsai","year":"2014","unstructured":"Tsai FC, Seki A, Yang HW, Hayer A, Carrasco S, Malmersj\u00f6 S, et al. A polarized Ca2+, diacylglycerol and STIM1 signalling system regulates directed cell migration. Nat Cell Biol. 2014;16(2):133\u201344.","journal-title":"Nat Cell Biol"},{"issue":"7231","key":"1643_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nature07577","volume":"457","author":"C Wei","year":"2009","unstructured":"Wei C, Wang X, Chen M, Ouyang K, Song LS, Cheng H. Calcium flickers steer cell migration. Nature. 2009;457(7231):901\u20135. https:\/\/doi.org\/10.1038\/nature07577.","journal-title":"Nature."},{"issue":"136","key":"1643_CR42","doi-asserted-by":"publisher","first-page":"20170490","DOI":"10.1098\/rsif.2017.0490","volume":"14","author":"JCL Alfonso","year":"2017","unstructured":"Alfonso JCL, Talkenberger K, Seifert M, Klink B, Hawkins-Daarud A, Swanson KR, et al. The biology and mathematical modelling of glioma invasion: a review. J R Soc Interface. 2017;14(136):20170490.","journal-title":"J R Soc Interface."},{"issue":"19","key":"1643_CR43","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1523\/JNEUROSCI.21-19-07674.2001","volume":"21","author":"CB Ransom","year":"2001","unstructured":"Ransom CB, O\u2019Neal JT, Sontheimer H. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci. 2001;21(19):7674\u201383.","journal-title":"J Neurosci"},{"issue":"3","key":"1643_CR44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1593\/neo.07928","volume":"10","author":"F Lefranc","year":"2008","unstructured":"Lefranc F, Kiss R. The sodium pump \u03b11 subunit as a potential target to combat apoptosis-resistant glioblastomas. Neoplasia. 2008;10(3):198\u2013206. https:\/\/doi.org\/10.1593\/neo.07928.","journal-title":"Neoplasia."},{"issue":"10","key":"1643_CR45","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/hr.2009.112","volume":"32","author":"Y Liu","year":"2009","unstructured":"Liu Y, Yang J, Ren H, He D, Pascua A, Armando MI, et al. Inhibitory effect of ETB receptor on Na+-K+ ATPase activity by extracellular Ca2+ entry and Ca2+ release from the endoplasmic reticulum in renal proximal tubule cells. Hypertens Res. 2009;32(10):846\u201352.","journal-title":"Hypertens Res"},{"issue":"9","key":"1643_CR46","doi-asserted-by":"publisher","first-page":"C1271","DOI":"10.1152\/ajpcell.00456.2011","volume":"302","author":"O Vagin","year":"2012","unstructured":"Vagin O, Dada LA, Tokhtaeva E, Sachs G. The Na-K-ATPase \u03b11\u03b21 heterodimer as a cell adhesion molecule in epithelia. Am J Physiol Cell Physiol. 2012;302(9):C1271\u201381.","journal-title":"Am J Physiol Cell Physiol."},{"issue":"6","key":"1643_CR47","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1083\/jcb.104.6.1587","volume":"104","author":"H Antonicek","year":"1987","unstructured":"Antonicek H, Persohn E, Schachner M. Biochemical and functional characterization of a novel neuron-glia adhesion molecule that is involved in neuronal migration. J Cell Biol. 1987;104(6):1587\u201395.","journal-title":"J Cell Biol"},{"key":"1643_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1083\/jcb.110.1.165","volume":"110","author":"S Gloor","year":"1990","unstructured":"Gloor S, Antonicek H, Sweadner KJ, Pagliusi S, Frank R, Moss M, et al. The Adhesion Molecule on Glia (AMOG) Is a Homologue of the B Subunit of the Na. K-ATPase J Cell Biol. 1990;110:165\u201374.","journal-title":"K-ATPase J Cell Biol"},{"issue":"4","key":"1643_CR49","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1046\/j.1365-2990.2003.00473.x","volume":"29","author":"V Senner","year":"2003","unstructured":"Senner V, Schmidtpeter S, Braune S, P\u00fcttmann S, Thanos S, Bartsch U, et al. AMOG\/\u03b22 and glioma invasion: Does loss of AMOG make tumour cells run amok? Neuropathol Appl Neurobiol. 2003;29(4):370\u20137.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"11","key":"1643_CR50","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1093\/neuonc\/not099","volume":"15","author":"MZ Sun","year":"2013","unstructured":"Sun MZ, Kim JM, Oh MC, Safaee M, Kaur G, Clark AJ, et al. Na+\/K+-ATPase b2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro Oncol. 2013;15(11):1518\u201331.","journal-title":"Neuro Oncol"},{"issue":"6","key":"1643_CR51","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1083\/jcb.133.6.1403","volume":"133","author":"M Chrzanowska-Wodnicka","year":"1996","unstructured":"Chrzanowska-Wodnicka M, Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol. 1996;133(6):1403\u201315.","journal-title":"J Cell Biol"},{"key":"1643_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.273.5272.245","volume":"273","author":"K Kimura","year":"1996","unstructured":"Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by rho and rho-associated kinase (rho-kinase). Science. 1996;273:245\u201358.","journal-title":"Science."},{"issue":"5304","key":"1643_CR53","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1126\/science.275.5304.1308","volume":"275","author":"M Amano","year":"2016","unstructured":"Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsura W, et al. Formation of actin stress fibers and focal adhesions enhanced by rho-kinase. Science (80- ). 2016;275(5304):1308\u201311.","journal-title":"Science (80- )."},{"issue":"3","key":"1643_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/11056","volume":"1","author":"N Watanabe","year":"1999","unstructured":"Watanabe N, Kato T, Fujita A, Ishizaki T, Narumiya S. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol. 1999;1(3):136\u201343.","journal-title":"Nat Cell Biol"},{"issue":"24","key":"1643_CR55","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1111\/bph.12704","volume":"171","author":"CM Fife","year":"2014","unstructured":"Fife CM, McCarroll JA, Kavallaris M. Movers and shakers: cell cytoskeleton in cancer metastasis. Br J Pharmacol. 2014;171(24):5507\u201323.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"1643_CR56","first-page":"1602","volume":"63","author":"CL Nutt","year":"2003","unstructured":"Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003;63(7):1602\u20137.","journal-title":"Cancer Res"},{"issue":"2","key":"1643_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/bj3610243","volume":"361","author":"MA Forget","year":"2002","unstructured":"Forget MA, Desrosiers RR, Gingras D, B\u00e9liveau R. Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J. 2002;361(2):243\u201354.","journal-title":"Biochem J"},{"issue":"18","key":"1643_CR58","first-page":"5336","volume":"62","author":"Q Ding","year":"2002","unstructured":"Ding Q, Stewart J, Prince CW, Chang PL, Trikha M, Han X, et al. Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res. 2002;62(18):5336\u201343.","journal-title":"Cancer Res"},{"key":"1643_CR59","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/cancers11050643","volume":"11","author":"IE Palam\u00e0","year":"2019","unstructured":"Palam\u00e0 IE, Amone SD, Ratano P, Donatelli A, Liscio A, Antonacci G, et al. Mechanical durotactic environment enhances specific glioblastoma cell response. Cancers. 2019;11:643.","journal-title":"Cancers"},{"issue":"24","key":"1643_CR60","doi-asserted-by":"publisher","first-page":"11709","DOI":"10.1158\/0008-5472.CAN-06-1878","volume":"66","author":"L Goldberg","year":"2006","unstructured":"Goldberg L, Kloog Y. A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration. Cancer Res. 2006;66(24):11709\u201317.","journal-title":"Cancer Res"},{"issue":"3","key":"1643_CR61","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.mcn.2011.12.003","volume":"49","author":"V Caraballo-Miralles","year":"2012","unstructured":"Caraballo-Miralles V, Cardona-Rossinyol A, Garcera A, Villalonga P, Soler RM, Olmos G, et al. SMN deficiency attenuates migration of U87MG astroglioma cells through the activation of RhoA. Mol Cell Neurosci. 2012;49(3):282\u20139. https:\/\/doi.org\/10.1016\/j.mcn.2011.12.003.","journal-title":"Mol Cell Neurosci."},{"issue":"1","key":"1643_CR62","first-page":"119","volume":"29","author":"VM Zohrabian","year":"2009","unstructured":"Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M. Rho\/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res. 2009;29(1):119\u201323.","journal-title":"Anticancer Res"},{"issue":"19","key":"1643_CR63","doi-asserted-by":"publisher","first-page":"8792","DOI":"10.1158\/0008-5472.CAN-05-0160","volume":"65","author":"B Salhia","year":"2005","unstructured":"Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, Kwan A, et al. Inhibition of rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res. 2005;65(19):8792\u2013800.","journal-title":"Cancer Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12935-020-01643-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:49:43Z","timestamp":1670262583000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-020-01643-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1643"],"URL":"https:\/\/doi.org\/10.1186\/s12935-020-01643-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.24065\/v1","asserted-by":"object"}]},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"576"}}